Bath & Body Works, Inc. $BBWI Shares Sold by Brant Point Investment Management LLC

Key Points

• Brant Point Investment Management LLC significantly reduced its stake in Bath & Body Works by 69.6%, selling 90,485 shares and lowering its holdings to 39,515 shares valued at approximately $1.2 million.
• Several other institutional investors made changes to their positions during the first quarter, with some increasing their stakes, indicating ongoing interest in the company.
• Bath & Body Works recently declared a $0.20 quarterly dividend, yielding 2.5%, set to be paid to investors of record on August 22nd.

Brant Point Investment Management LLC lessened its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 69.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,515 shares of the company's stock after selling 90,485 shares during the period. Brant Point Investment Management LLC's holdings in Bath & Body Works were worth $1,198,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of BBWI. Wealth Enhancement Advisory Services LLC boosted its position in Bath & Body Works by 38.9% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock valued at $1,265,000 after buying an additional 11,681 shares during the last quarter. Kovitz Investment Group Partners LLC purchased a new stake in Bath & Body Works in the fourth quarter valued at approximately $258,000. Merit Financial Group LLC purchased a new stake in Bath & Body Works in the first quarter valued at approximately $714,000. Nuveen Asset Management LLC boosted its position in Bath & Body Works by 3.7% in the fourth quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock valued at $29,628,000 after buying an additional 27,136 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its position in Bath & Body Works by 3,642.2% in the first quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock valued at $50,062,000 after buying an additional 1,606,988 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Down 0.4%

Shares of BBWI stock traded down $0.13 during trading hours on Monday, hitting $29.23. 6,942,370 shares of the company's stock were exchanged, compared to its average volume of 5,505,582. The firm has a market cap of $6.03 billion, a P/E ratio of 8.67, a P/E/G ratio of 0.98 and a beta of 1.49. The firm has a 50 day moving average of $30.63 and a two-hundred day moving average of $30.74. Bath & Body Works, Inc. has a fifty-two week low of $24.94 and a fifty-two week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same period in the prior year, the company earned $0.37 EPS. The firm's revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Investors of record on Friday, August 22nd will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Friday, August 22nd. Bath & Body Works's dividend payout ratio is currently 23.74%.

Analyst Ratings Changes

A number of brokerages have issued reports on BBWI. Morgan Stanley decreased their price target on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Barclays boosted their price target on Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a report on Friday. The Goldman Sachs Group decreased their price target on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. JPMorgan Chase & Co. boosted their price target on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. Finally, UBS Group decreased their price target on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a report on Friday. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of "Moderate Buy" and a consensus target price of $41.62.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.